Literature DB >> 11490292

Outcome analysis of vesicoamniotic shunting in a comprehensive population.

G McLorie1, W Farhat, A Khoury, D Geary, G Ryan.   

Abstract

PURPOSE: Prenatal detection of obstructive uropathy is used widely and vesicoamniotic shunting is the accepted procedure in well-defined cases. We present outcomes of vesicoamniotic shunting in a consecutive series from a coordinated prenatal-postnatal treatment program.
MATERIALS AND METHODS: From 1989 to 1998 bladder obstruction was identified in 89 fetuses at a multidisciplinary prenatal high risk clinic. Prenatal intervention was considered in cases of bilateral hydronephrosis associated with evidence of bladder outlet obstruction and oligohydramnios.
RESULTS: Indications for prenatal shunting were present in 12 patients (13%), and 9 underwent vesicoamniotic shunt insertion between weeks 20 and 28 of gestation. None of the prenatal procedures was associated with preterm labor, chorioamnionitis or urine chemistry values greater than cutoff threshold on bladder tap. Shunts were extruded from 2 fetuses, which required sequential insertion. After prenatal intervention 1 patient elected pregnancy termination and the others proceeded to term. Two neonates died at birth, and 6 survived. The underlying urological diagnosis was posterior urethral valves in 4 newborns, urethral atresia in 1, and prune belly variant and urethral atresia in 1. Of the patients 3 had relatively normal renal function, 2 had severe renal insufficiency and 1 had mild renal impairment. Five newborns are voiding freely and 1 underwent bladder reconstruction and is on intermittent catheterization. None of the patients had pulmonary problems at last followup.
CONCLUSIONS: Although vesicoamniotic shunting is effective in reversing oligohydramnios, its ability to achieve sustainable good renal function in infancy is variable. No specific prenatal parameters were effective in predicting eventual good renal function. Pulmonary function cannot be assured with restoration of amniotic fluid.

Entities:  

Mesh:

Year:  2001        PMID: 11490292

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Fetal therapy.

Authors:  Srikumar B Pillai; Santhanam Suresh
Journal:  Indian J Pediatr       Date:  2003-05       Impact factor: 1.967

Review 2.  Management of fetal hydronephrosis.

Authors:  Jenny Yiee; Duncan Wilcox
Journal:  Pediatr Nephrol       Date:  2007-08-02       Impact factor: 3.714

3.  Antenatally Diagnosed Posterior Urethral Valves: A Dilemma.

Authors:  R Panicker; D S Grewal
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  In utero intervention for urologic diseases.

Authors:  Douglass B Clayton; John W Brock
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

Review 5.  Current State of Fetal Intervention for Lower Urinary Tract Obstruction.

Authors:  Douglass B Clayton; John W Brock
Journal:  Curr Urol Rep       Date:  2018-02-22       Impact factor: 3.092

Review 6.  Antenatal hydronephrosis: evaluation and outcome.

Authors:  Christopher S Cooper; Janet I Andrews; Wendy F Hansen; Jerome Yankowitz
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 2.862

7.  Posterior urethral valves: renal failure and prenatal treatment.

Authors:  Daniel P Casella; Jeffrey J Tomaszewski; Michael C Ost
Journal:  Int J Nephrol       Date:  2011-08-09

8.  Long-term outcomes of kidney and bladder function in patients with a posterior urethral valve.

Authors:  Sung Jin Kim; Jaeyoon Jung; Chanwoo Lee; Sejun Park; Sang Hoon Song; Hye-Sung Won; Kun Suk Kim
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Revised guidelines on management of antenatal hydronephrosis.

Authors:  A Sinha; A Bagga; A Krishna; M Bajpai; M Srinivas; R Uppal; I Agarwal
Journal:  Indian J Nephrol       Date:  2013-03

10.  Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.

Authors:  Jeffrey T White; Kunj R Sheth; Aylin N Bilgutay; David R Roth; Paul F Austin; Edmond T Gonzales; Nicolette K Janzen; Duong D Tu; Angela G Mittal; Chester J Koh; Sheila L Ryan; Carolina Jorgez; Abhishek Seth
Journal:  Front Pediatr       Date:  2018-07-03       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.